Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Arthritis, Psoriatic
Interventions: Biological: CZP 200mg Q2W; Biological: CZP 400mg Q4W; Other: Placebo
Sponsor: UCB, Inc.
Recruiting - verified March 2010
Condition: Psoriasis
Intervention: Radiation: UVB-311nm radiation
Sponsor: Medical University of Graz
Recruiting - verified March 2010
Conditions: Psoriasis; Cardiovascular Diseases; Diabetes Mellitus, Type 2
Interventions: Drug: Adalimumab treatment arm; Drug: Fumaric acid esters treatment group; Other: Narrow band UVB radiation
Sponsor: Medical University of Vienna
Not yet recruiting - verified March 2010
Conditions: Crohn's Disease; Rheumatoid Arthritis
Intervention:
Sponsors: University of California, San Diego; Organization of Teratology Information Specialists (OTIS); Abbott
Recruiting - verified March 2010
Conditions: Osteoarthritis; Arthritis; Pain
Interventions: Biological: Placebo; Biological: tanezumab; Biological: tanezumab; Biological: tanezumab; Biological: tanezumab
Sponsor: Pfizer
Not yet recruiting - verified March 2010
Condition: Lupus Arthritis
Interventions: Drug: Laquinimod; Drug: Laquinimod; Other: Placebo
Sponsor: Teva Pharmaceutical Industries
Not yet recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Intervention: Drug: tocilizumab [RoActemra/Actemra]
Sponsor: Hoffmann-La Roche
Not yet recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Intervention:
Sponsor: University of Rochester
Recruiting - verified March 2010
Conditions: Rheumatoid Arthritis; Arthritis, Psoriatic; Ankylosing Spondylitis
Interventions: Biological: golimumab; Biological: anti-TNF biologics; Biological: non-anti-TNF biologics; Drug: systemic non-biological treatments; Other: general population
Sponsor: Centocor Ortho Biotech Services, L.L.C.
Not yet recruiting - verified March 2010
Condition: Autoimmune Disease
Intervention: Drug: Rituximab
Sponsor: National Eye Institute (NEI)
Recruiting - verified October 2009
Conditions: Rheumatoid Arthritis; Psoriatic Arthritis; Ankylosing Spondylitis
Intervention: Biological: HUMIRA (adalimumab)
Sponsors: Abbott; Veeda Clinical Research, Brussels
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Intervention: Other: This is a non-drug study. No treatment is mandated by the protocol. Routine blood draws (as per normal clinical care) will be taken through the study.
Sponsors: Abbott; Clinical Trial End-Point (CTEP) Ltd; JSS Medical Research Inc.
Not yet recruiting - verified March 2010
Condition: Spondolyarthropathies
Interventions: Biological: Certolizumab pegol; Biological: Certolizumab pegol; Other: Placebo
Sponsor: UCB, Inc.
Recruiting - verified March 2010
Conditions: Rheumatoid Arthritis; Psoriatic Arthritis; Ankylosing Spondylitis
Intervention:
Sponsor: Abbott
Recruiting - verified February 2010
Conditions: Active Rheumatoid Arthritis; Osteoporoses
Intervention:
Sponsors: Abbott; Centre of Biostatistics and Analyses, Faculty of Medicine, Masaryk University Brno, Czech Republic
Recruiting - verified February 2010
Condition: Psoriatic Arthritis
Intervention: Biological: adalimumab (Humira)
Sponsor: Abbott
Not yet recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Intervention: Biological: adalimumab (Humira)
Sponsor: Abbott
Recruiting - verified February 2010
Condition: Arthritis, Psoriatic
Interventions: Drug: ustekinumab; Drug: placebo; Drug: placebo; Drug: ustekinumab; Drug: ustekinumab; Drug: placebo; Drug: ustekinumab; Drug: ustekinumab
Sponsor: Centocor, Inc.
Not yet recruiting - verified February 2010
Condition: Arthritis, Rheumatoid
Interventions: Drug: Matching placebo; Drug: Otelixizumab
Sponsor: GlaxoSmithKline
Not yet recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Intervention:
Sponsor: Abbott
Recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Intervention: Biological: adalimumab (Humira)
Sponsor: Abbott
Recruiting - verified February 2010
Condition: Arthritis, Rheumatoid
Intervention: Drug: Prednisone
Sponsor: Merck KGaA
Recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Intervention: Biological: adalimumab (Humira)
Sponsor: Abbott
Recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Intervention:
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Conditions: Anterior Cruciate Ligament Injury; Osteoarthritis
Interventions: Biological: MSB-CAR001 Combined With Hyaluronan; Drug: Hyaluronan
Sponsor: Mesoblast, Ltd.
Recruiting - verified March 2010
Condition: Acute Gout
Interventions: Drug: ACZ885; Drug: Triamcinolone acetonide
Sponsor: Novartis Pharmaceuticals
Recruiting - verified March 2010
Condition: Lupus Nephritis
Interventions: Drug: laquinimod 0.5mg + standard of care; Drug: laquinimod 1mg + standard of care; Other: placebo + standard of care
Sponsor: Teva Pharmaceutical Industries
Not yet recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Intervention:
Sponsor: Abbott
Recruiting - verified March 2010
Condition: Primary Sjögren Syndrome
Intervention: Biological: blood sample
Sponsor: University Hospital, Limoges
Recruiting - verified March 2010
Conditions: Arthritis, Rheumatoid; Spondylitis, Ankylosing
Intervention: Drug: TNF blockers (infliximab, adalimumab, etanercept)
Sponsor: University of Sao Paulo
Recruiting - verified January 2010
Condition: Severe Active Rheumatoid Arthritis According to the Current SPC
Intervention:
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Intervention:
Sponsor: Newcastle-upon-Tyne Hospitals NHS Trust
Not yet recruiting - verified February 2010
Condition: Sjogren's Syndrome
Intervention: Drug: FID 114657 (ORB Preserved Ocular Emulsion)
Sponsor: Alcon Research
Recruiting - verified March 2010
Conditions: Degenerative Joint Disease; Osteoarthritis; Total Knee Arthroplasty
Interventions: Device: PEAK PlasmaBlade 4.0; Device: Traditional Electrosurgery with scalpel
Sponsor: Peak Surgical, Inc.
Recruiting - verified March 2010
Condition: Joint Damage
Interventions: Drug: Febuxostat; Drug: Placebo
Sponsor: Takeda Global Research & Development Center, Inc.
Not yet recruiting - verified March 2010
Condition: Degenerative Arthritis of Knee
Intervention:
Sponsor: Smith & Nephew, Inc.
Not yet recruiting - verified March 2010
Conditions: Infection; Osteoarthritis of the Knee
Interventions: Device: Simplex™ P with Tobramycin; Device: Simplex™ P
Sponsor: University of Western Ontario, Canada
Not yet recruiting - verified March 2010
Condition: Ankylosing Spondylitis
Intervention: Drug: adalimumab (Humira)
Sponsor: Abbott
Recruiting - verified March 2010
Condition: Osteoarthritis, Knee
Intervention: Device: acupuncture
Sponsors: Massachusetts General Hospital; National Center for Complementary and Alternative Medicine (NCCAM); Harvard University; Brigham and Women's Hospital
Recruiting - verified March 2010
Condition: Coxarthrosis
Intervention: Drug: Corticosterone
Sponsor: University Hospital Pellenberg
Not yet recruiting - verified February 2010
Condition: Chronic Urticaria
Interventions: Drug: Placebo; Drug: Hydroxychloroquine
Sponsor: Vanderbilt University
Not yet recruiting - verified February 2010
Condition: Osteoarthritis
Intervention: Procedure: Total knee arthroplasty
Sponsor: Exactech
Recruiting - verified March 2010
Condition: Knee Osteoarthritis
Interventions: Dietary Supplement: Glucosamine sulphate; Other: Placebo
Sponsor: University of British Columbia
Not yet recruiting - verified February 2010
Conditions: Pain; Inflammation
Intervention: Dietary Supplement: tart cultivar Montmorency cherry juice
Sponsors: Oregon Health and Science University; Cherry Research Committee
Not yet recruiting - verified February 2010
Conditions: Osteoarthritis; Pain
Interventions: Drug: MEDI-578; Drug: Placebo for MEDI-578
Sponsors: AstraZeneca; MedImmune LLC
Recruiting - verified February 2010
Condition: Acute Gout
Interventions: Drug: ACZ885; Drug: Triamcinolone acetonide
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Intervention: Drug: tocilizumab [RoActemra/Actemra]
Sponsor: Hoffmann-La Roche
Not yet recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: SAR153191(REGN88); Drug: placebo
Sponsors: Sanofi-Aventis; Regeneron Pharmaceuticals
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: CP-690,550; Drug: Atorvastatin; Drug: CP-690,550; Drug: Atorvastatin Placebo
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Osteoarthritis, Hip
Intervention:
Sponsor: Smith & Nephew, Inc.
Recruiting - verified March 2010
Condition: Osteoarthritis, Hip
Intervention:
Sponsor: Smith & Nephew, Inc.
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: Placebo; Drug: VX-509; Drug: VX-509; Drug: VX-509; Drug: VX-509
Sponsor: Vertex Pharmaceuticals Incorporated
Recruiting - verified March 2010
Condition: Ankylosing Spondylitis
Interventions: Drug: SAR153191 (REGN88); Drug: placebo
Sponsors: Sanofi-Aventis; Regeneron Pharmaceuticals
Recruiting - verified March 2010
Condition: Osteoarthritis
Interventions: Drug: LT-NS001; Drug: Naprosyn®
Sponsors: Logical Therapeutics; PRA International
Recruiting - verified February 2010
Condition: Osteoarthritis
Intervention:
Sponsor: Biomet, Inc.
Not yet recruiting - verified March 2010
Condition: Arthritis, Rheumatoid
Interventions: Drug: CP-690,550; Drug: CP-690,550; Drug: Disease-modifying antirheumatic drug
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: CF101; Drug: Placebo control
Sponsor: Can-Fite BioPharma
Not yet recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra]; Drug: methotrexate; Drug: placebo TCZ; Drug: placebo MTX
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra]; Drug: placebo; Drug: non-biological DMARDs
Sponsor: Hoffmann-La Roche
Not yet recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Intervention: Drug: CCX 354-C
Sponsor: ChemoCentryx
Recruiting - verified March 2010
Condition: Breast Cancer
Intervention: Drug: Duloxetine
Sponsors: University of Michigan Cancer Center; Eli Lilly and Company
Recruiting - verified February 2010
Condition: Arthritis, Rheumatoid
Intervention: Drug: CP 690,550 oral solutions
Sponsor: Pfizer
Not yet recruiting - verified February 2010
Condition: Osteoarthritis Knee Pain
Interventions: Drug: Duloxetine; Drug: Placebo
Sponsor: Eli Lilly and Company
Recruiting - verified March 2010
Condition: Acute Arthritis
Intervention:
Sponsor: University Hospital, Grenoble
Recruiting - verified March 2010
Condition: Arthritis, Psoriatic
Interventions: Drug: placebo; Drug: ustekinumab; Drug: ustekinumab; Drug: placebo; Drug: ustekinumab; Drug: ustekinumab; Drug: placebo; Drug: ustekinumab
Sponsor: Centocor, Inc.
Recruiting - verified February 2010
Condition: Active Rheumatoid Arthritis
Intervention: Drug: SBI-087
Sponsor: Wyeth
Recruiting - verified February 2010
Conditions: Arthritis; Rheumatoid Arthritis
Interventions: Biological: CDP6038; Biological: CDP6038; Biological: CDP6038; Biological: CDP6038; Biological: CDP6038; Biological: CDP6038; Other: Placebo IV; Other: Placebo SC
Sponsor: UCB, Inc.
Recruiting - verified March 2010
Conditions: Arthritis; Arthritis, Rheumatoid; Autoimmune Diseases
Interventions: Drug: golimumab; Drug: golimumab or placebo; Drug: golimumab or placebo
Sponsors: Centocor, Inc.; Schering-Plough
Recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: Abatacept; Drug: Abatacept; Drug: Abatacept; Drug: Placebo
Sponsor: Bristol-Myers Squibb
Recruiting - verified December 2009
Condition: Rheumatoid Arthritis
Interventions: Drug: rituximab [MabThera/Rituxan]; Drug: methotrexate; Drug: methylprednisolone
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra]; Drug: DMARDs
Sponsor: Hoffmann-La Roche
Not yet recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: Placebo of CDP870; Drug: CDP870 200mg
Sponsor: Korea Otsuka Pharmaceutical Co.,Ltd.
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Interventions: Biological: Placebo; Biological: Certolizumab pegol
Sponsor: UCB, Inc.
Recruiting - verified March 2010
Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: tocilizumab [RoActemra]; Drug: tocilizumab [RoActemra]; Drug: tocilizumab [RoActemra]; Drug: placebo; Drug: NSAIDs, corticosteroids, methotrexate
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Conditions: Osteoarthritis, Knee; Osteoarthritis, Hip
Interventions: Other: Tanezumab 2.5 mg; Other: Tanezumab 5 mg; Other: Tanezumab 10 mg
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Osteoarthritis
Interventions: Biological: tanezumab 10 mg; Biological: tanezumab 5 mg; Drug: oxycodone; Other: placebo
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: GSK706769; Drug: Placebo
Sponsor: GlaxoSmithKline
Not yet recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: CP-690,550 + methotrexate; Drug: Placebo + Methotrexate
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Osteoarthritis, Knee
Interventions: Drug: PF-04457845; Drug: PF-04457845; Drug: Naproxen; Drug: Naproxen
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Arthritis, Rheumatoid
Interventions: Drug: placebo; Biological: golimumab; Biological: golimumab; Biological: golimumab
Sponsors: Centocor, Inc.; Schering-Plough
Recruiting - verified February 2010
Conditions: Chronic Allograft Nephropathy; Chronic Kidney Disease; Chronic Renal Failure; Disordered Mineral Metabolism; End Stage Renal Disease; Hyperparathyroidism; Hypophosphatemia; Kidney Disease; Kidney Transplantation; Post Renal Transplantation
Interventions: Drug: Placebo; Drug: Cinacalcet
Sponsor: Amgen
Not yet recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Interventions: Biological: LY2439821; Drug: Placebo
Sponsor: Eli Lilly and Company
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Intervention: Drug: Rituximab
Sponsors: University of Manitoba; Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Arthritis, Rheumatoid
Interventions: Biological: SC golimumab; Biological: IV golimumab
Sponsor: Schering-Plough
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra]; Drug: placebo; Drug: tocilizumab [RoActemra]
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Osteoarthritis
Interventions: Biological: Tanezumab; Biological: Tanezumab; Other: Placebo
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Arthritis, Rheumatoid
Interventions: Drug: CP-690,550; Drug: CP-690,550; Drug: Placebo; Drug: CP-690,550; Drug: Placebo; Drug: CP-690,550
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Systemic Lupus Erythematosus
Interventions: Drug: placebo; Drug: rontalizumab
Sponsor: Genentech
Recruiting - verified February 2010
Condition: Sarcoidosis
Interventions: Drug: Placebo; Drug: golimumab; Drug: ustekinumab
Sponsor: Centocor, Inc.
Recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: AMG 827 70 mg; Drug: AMG 827 140 mg; Drug: AMG 827 210 mg; Drug: Placebo
Sponsor: Amgen
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra]; Drug: Standard DMARDs (Disease Modifying Anti Rheumatic Drugs)
Sponsor: Hoffmann-La Roche
Not yet recruiting - verified February 2010
Condition: Psoriasis
Intervention: Biological: teplizumab
Sponsors: MacroGenics; Eli Lilly and Company
Recruiting - verified March 2010
Condition: Osteoarthritis of the Knee
Interventions: Drug: Glucosamine sulphate and chondroitin sulphate association; Drug: Condroflex (Zodiac)
Sponsor: Eurofarma Laboratorios Ltda
Not yet recruiting - verified August 2009
Condition: Rheumatoid Arthritis, Arthritis,
Intervention: Drug: JNJ 38518168 or placebo
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: PF-04171327 10 mg; Other: Prednisone Placebo; Drug: PF-04171327 25 mg; Other: Prednisone Placebo; Drug: Prednisone 5 mg; Other: Placebo for PF-04171327; Other: Placebo; Other: Placebo for PF-04171327
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Osteoarthritis, Knee
Interventions: Biological: PG110 (anti-nerve growth factor monoclonal antibodyPlacebo to match PG110; Drug: Placebo
Sponsor: Abbott
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: Abatacept; Drug: Adalimumab
Sponsor: Bristol-Myers Squibb
Recruiting - verified December 2009
Condition: Osteoarthritis, Knee
Intervention: Drug: JNJ-39439335; Placebo; Naproxen
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Recruiting - verified February 2010
Conditions: Head and Neck Neoplasms; Pheochromocytoma; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell
Intervention: Drug: Fostamatinib disodium (R9355788)
Sponsor: National Cancer Institute (NCI)
Recruiting - verified March 2010
Conditions: Frozen Shoulder; Impairment Glucose Tolerance
Intervention:
Sponsor: Hadassah Medical Organization
Recruiting - verified February 2010
Conditions: Active Rheumatoid Arthritis; Arthritis, Rheumatoid; Rheumatoid Arthritis
Interventions: Drug: etanercept; Drug: methotrexate
Sponsor: Wyeth
Recruiting - verified March 2010
Condition: Osteoarthritis Pain
Interventions: Procedure: Comparator: Iontophoresis and Laser Doppler with ATP; Procedure: Comparator: Iontophoresis and Laser Doppler with Saline
Sponsor: Merck
Recruiting - verified March 2010
Condition: Systemic Juvenile Idiopathic Arthritis
Intervention: Drug: Canakinumab
Sponsors: Novartis Pharmaceuticals; PRINTO / PRCSG
Recruiting - verified August 2009
Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra]; Drug: tocilizumab [RoActemra]; Drug: Nonbiologic DMARDs of investigator's choice
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Intervention:
Sponsor: Wyeth
Recruiting - verified March 2010
Condition: Systemic Juvenile Idiopathic Arthritis
Interventions: Drug: Canakinumab; Drug: Placebo
Sponsors: Novartis Pharmaceuticals; PRINTO / PRCSG
Recruiting - verified August 2009
Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra]; Drug: tocilizumab [RoActemra]
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Systemic Juvenile Idiopathic Arthritis With Active Flare
Interventions: Drug: Canakinumab; Drug: Placebo
Sponsors: Novartis Pharmaceuticals; PRINTO / PRCSG
Recruiting - verified December 2009
Condition: Rheumatoid Arthritis
Interventions: Biological: Adalimumab; Drug: Placebo
Sponsors: Abbott; Abbott Japan Co.,Ltd; Eisai Limited
Recruiting - verified February 2010
Condition: Spinal Cord Injury
Intervention:
Sponsor: Department of Veterans Affairs
Recruiting - verified March 2010
Condition: Osteoarthritis
Interventions: Biological: tanezumab; Biological: tanezumab; Other: Placebo
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Osteoarthritis
Interventions: Biological: tanezumab; Drug: diclofenac; Biological: tanezumab; Drug: diclofenac; Biological: tanezumab; Drug: diclofenac; Drug: diclofenac
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Osteoarthritis
Interventions: Biological: tanezumab 10 mg; Biological: tanezumab 5 mg; Drug: naproxen; Other: placebo
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: Etanercept; Drug: Etanercept; Drug: Placebo
Sponsor: Wyeth
Recruiting - verified March 2010
Condition: Arthritis, Rheumatoid
Interventions: Drug: CP-690,550; Drug: CP-690,550; Drug: Placebo; Drug: Placebo
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: CP 690,550; Drug: CP-690,550; Other: Placebo; Other: Placebo; Biological: Biologic TNFi
Sponsor: Pfizer
Recruiting - verified March 2010
Conditions: Osteoarthritis; Traumatic Arthritis; Avascular Necrosis of the Femoral Condyle; Moderate Varus; Valgus; Flexion Deformities
Intervention: Device: NexGen LPS-Flex Mobile Bearing Knee
Sponsor: Zimmer, Inc.
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: Etanercept; Drug: Methotrexate; Drug: Sulfasalazine; Drug: Hydroxychloroquine
Sponsor: Wyeth
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra]; Drug: rituximab [MabThera/Rituxan]; Drug: Placebo
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Conditions: Polymyalgia Rheumatica; Rheumatoid Arthritis; Rheumatic Disease
Intervention:
Sponsor: Lahey Clinic
Recruiting - verified March 2010
Condition: Systemic Sclerosis
Intervention: Drug: treprostinil diethanolamine
Sponsor: United Therapeutics
Not yet recruiting - verified February 2009
Condition: Rheumatoid Arthritis
Interventions: Drug: Placebo; Drug: dose level 1; Drug: dose level 2; Drug: dose level 3; Drug: dose level 4
Sponsor: Pfizer
Recruiting - verified March 2010
Conditions: Chronic Sinusitis; Chronic Rhinosinusitis; Nasal Polyps
Intervention: Drug: Prednisone
Sponsor: Northwestern University
Recruiting - verified February 2010
Conditions: Ankylosing Spondylitis; Axial Spondyloarthritis
Interventions: Drug: infliximab infusion; Drug: placebo infusion; Drug: naproxen (Treatment Phase); Drug: naproxen (Follow-Up Phase); Other: no intervention (Follow-Up Phase)
Sponsor: Schering-Plough
Recruiting - verified March 2010
Conditions: Arthritis; Osteoarthritis
Interventions: Biological: tanezumab 10 mg; Biological: tanezumab 5 mg; Drug: naproxen; Other: placebo
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Osteoarthritis
Interventions: Drug: Naproxen; Drug: Placebo
Sponsors: Pfizer; King's College London; St Thomas' Hospital, London
Not yet recruiting - verified March 2010
Conditions: Degenerative Joint Disease; Osteoarthritis; Rheumatoid Arthritis; Traumatic Arthritis
Intervention: Device: 3DKnee™ System
Sponsor: Encore Medical, L.P.
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Intervention: Drug: tocilizumab [RoActemra]
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra]; Drug: methotrexate; Drug: placebo
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Conditions: Osteoarthritis; Arthritis
Interventions: Drug: NSAID; Biological: tanezumab; Biological: tanezumab; Biological: tanezumab; Drug: NSAID; Biological: tanezumab; Drug: NSAID
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Arthritis, Rheumatoid
Interventions: Biological: adalimumab; Drug: methotrexate
Sponsors: Abbott; Pharma Consulting Group
Recruiting - verified February 2010
Condition: Osteoarthritis
Interventions: Biological: tanezumab; Biological: tanezumab; Biological: tanezumab
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Arthritis, Juvenile Rheumatoid
Interventions: Drug: Celecoxib; Drug: Naproxen
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Fibromyalgia
Interventions: Drug: Sodium Oxybate; Drug: Sodium Oxybate & Tablet; Drug: Sodium Oxybate & Tablets; Drug: Sodium Oxybate Oral Solution (6 grams)
Sponsor: Jazz Pharmaceuticals
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Intervention:
Sponsor: Wyeth
Recruiting - verified March 2010
Conditions: Systemic Sclerosis; Scleroderma
Interventions: Drug: treprostinil diethanolamine; Drug: placebo
Sponsor: United Therapeutics
Recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Intervention: Drug: Abatacept
Sponsor: Bristol-Myers Squibb
Recruiting - verified January 2010
Conditions: NOMID; CINCA Syndrome
Interventions: Drug: Canakinumab; Drug: ACZ885
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified September 2009
Conditions: Spondylitis, Ankylosing; Arthritis, Rheumatoid
Interventions: Biological: infliximab; Biological: infliximab
Sponsor: Schering-Plough
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra]; Drug: methotrexate
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Ankylosing Spondylitis
Interventions: Drug: Celecoxib; Drug: Diclofenac SR
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Intervention: Drug: Curcumin (Longvida™)
Sponsor: University of California, Los Angeles
Recruiting - verified September 2008
Conditions: Arthritis; Osteoarthritis; Osteoarthritis, Hip
Interventions: Biological: tanezumab; Biological: tanezumab; Biological: tanezumab; Biological: Placebo
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Psoriasis
Intervention: Drug: CNTO 1275; Ustekinumab
Sponsor: Centocor, Inc.
Recruiting - verified February 2010
Conditions: Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Psoriatic
Intervention: Other: Data collection post infusion
Sponsor: Schering-Plough
Recruiting - verified March 2010
Conditions: Pain; Osteoarthritis, Hip; Analgesia
Interventions: Drug: Etoricoxib 60 mg; Drug: Placebo for Etoricoxib 60 mg; Drug: Etoricoxib 60 mg; Drug: Placebo for Etoricoxib 60 mg
Sponsors: University of Erlangen-Nürnberg Medical School; HELIOS Kliniken GmbH; Rush University Medical Center; Merck
Recruiting - verified March 2010
Condition: Sjogren's Disease
Interventions: Drug: Rituximab (mabthera) Injection; Drug: Placebo: NaCl 0.9% or Glucose 5%
Sponsors: University Hospital, Brest; Ministry of Health, France
Recruiting - verified March 2010
Condition: Osteoarthritis
Interventions: Device: Uniglide Mobile Bearing Unicondylar Knee System; Device: Uniglide Fixed Bearing Unicondylar Knee System
Sponsor: Corin
Recruiting - verified February 2010
Conditions: Crohn Disease; Rheumatoid Arthritis
Intervention: Biological: Infliximab
Sponsors: Schering-Plough; Centocor, Inc.
Recruiting - verified March 2010
Conditions: Osteoarthritis; Avascular Necrosis; Rheumatoid Arthritis
Intervention: Device: Cormet Hip Resurfacing
Sponsor: Corin
Recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Intervention: Drug: CNTO 136
Sponsor: Centocor, Inc.
Recruiting - verified February 2010
Conditions: Spinal Spondyloarthropathies; Axial Spondyloarthritis
Intervention:
Sponsor: Schering-Plough
Recruiting - verified March 2010
Conditions: Crohn's Disease; Ankylosing Spondylitis
Intervention: Biological: Infliximab
Sponsor: Schering-Plough
Recruiting - verified March 2010
Condition: Arthritis, Juvenile Rheumatoid
Interventions: Drug: Celecoxib; Drug: nsNSAIDs
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Arthritis, Rheumatoid
Interventions: Drug: Placebo; Drug: CP-690,550; Drug: CP-690,550; Drug: CP-690,550; Drug: CP-690,550; Drug: CP-690,550
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Arthritis, Juvenile Rheumatoid
Intervention: Drug: Sulfasalazine
Sponsor: Pfizer
Not yet recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Intervention: Drug: CP-690,550
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: Liquid Certolizumab pegol; Drug: Liquid Certolizumab pegol; Other: Placebo; Drug: Methotrexate
Sponsor: UCB, Inc.
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: rituximab [MabThera/Rituxan]; Drug: Methotrexate
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Osteoarthritis
Interventions: Drug: SD-6010; Drug: SD-6010; Drug: Placebo
Sponsor: Pfizer
Recruiting - verified March 2010
Conditions: Psoriasis; Arthritis, Psoriatic
Interventions: Drug: conventional systemic agents; Biological: infliximab; Biological: ustekinumab; Biological: Biological therapies other than infliximab and ustekinumab
Sponsor: Centocor Ortho Biotech Services, L.L.C.
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Intervention: Drug: rituximab [MabThera/Rituxan]
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Intervention: Drug: rituximab [MabThera/Rituxan]
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Advanced Glenohumeral Arthritis
Intervention: Device: Humeral surface replacement hemiarthroplasty (CAP)
Sponsors: University of Calgary; DePuy International; Johnson & Johnson
Recruiting - verified March 2010
Condition: Osteoarthritis
Interventions: Other: proprietary cherry juice blend (food); Other: control juice (kool aid blend)
Sponsor: CherryPharm
Recruiting - verified March 2010
Condition: Systemic Lupus Erythematosus
Interventions: Drug: steroids (prednisone or prednisolone) + MMF; Drug: abatacept; Drug: abatacept
Sponsor: Bristol-Myers Squibb
Recruiting - verified March 2010
Condition: Arthritis, Rheumatoid
Intervention: Other: CP-690,550
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Arthritis, Rheumatoid
Interventions: Drug: CP-690,550; Drug: CP-690,550
Sponsor: Pfizer
Recruiting - verified March 2010
Conditions: Osteoarthritis; Osteosarcoma; Scoliosis; Cerebral Palsy
Intervention:
Sponsor: University of Florida
Recruiting - verified February 2010
Condition: Osteoarthritis
Interventions: Drug: Celecoxib; Drug: Any commercially available NSAID with the indication for osteoarthritis
Sponsor: Pfizer
Recruiting - verified March 2010
Conditions: Arthritis, Rheumatoid; Osteoarthritis
Interventions: Drug: celecoxib; Drug: Ibuprofen; Drug: Naproxen
Sponsors: Pfizer; The Cleveland Clinic
Recruiting - verified March 2010
Conditions: Arthritis, Psoriatic; Psoriasis
Intervention: Drug: etanercept
Sponsor: Wyeth
Recruiting - verified March 2010
Conditions: Arthritis, Psoriatic; Psoriasis; Skin Diseases, Papulosquamous
Intervention: Drug: Etanercept
Sponsor: Wyeth
Recruiting - verified March 2010
Conditions: DVT; Osteoarthritis
Intervention: Drug: unfractionated heparin
Sponsor: Ottawa Hospital Research Institute
Recruiting - verified March 2010
Condition: Rheumatic Disease
Intervention:
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified April 2009
Conditions: Sjogren's Syndrome; Xerostomia
Intervention:
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR)
Recruiting - verified December 2009
All Categories ... Medical Conditions » ... Arthritis 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
